Content resistin plasma and nonspecific inflammation markers in patients with type 2 diabetes compensation from different diseases

Content resistin plasma and nonspecific inflammation markers in patients with type 2 diabetes compensation from different diseases

Gespeichert in:

Bibliographische Detailangaben
Datum:	2015
1. Verfasser:	A. M. Urbanovych
Format:	Artikel
Sprache:	English
Veröffentlicht:	2015
Schriftenreihe:	Actual problems of transport medicine: environment, occupational health, pathology
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0000594130
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

The blood leptin content and the activity of the zonal system response in patients with diabetes mellitus type 2 with different body weight and disease duration
von: B. M. Mankovskyi, et al.
Veröffentlicht: (2014)

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
von: M. D. Tronko, et al.
Veröffentlicht: (2021)

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
von: Tronko, M.D., et al.
Veröffentlicht: (2021)

Cardiovascular disease among patients with type 2 diabetes: Role of homocysteine as an inflammatory marker
von: A. Sahu, et al.
Veröffentlicht: (2016)

Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristic
von: Pamuk, G.E., et al.
Veröffentlicht: (2006)

Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
von: Tronko, M.D., et al.
Veröffentlicht: (2021)

Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
von: E. L. Tovazhnjanskaja, et al.
Veröffentlicht: (2014)

Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
von: Tovazhnyanska, E.L., et al.
Veröffentlicht: (2014)

Echographic markers of vascular and cardiac disorders in patients with arterial hypertension and arterial hypertension associated with type 2 diabetes mellitus
von: Ya. K. Radzishevska
Veröffentlicht: (2015)

Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
von: M. D. Tronko, et al.
Veröffentlicht: (2024)

The role of resistin in the genesis of metabolic disorders in pathological pregnancy
von: S. O. Ostafiichuk
Veröffentlicht: (2019)

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
von: M. D. Tronko, et al.
Veröffentlicht: (2021)

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
von: Tronko, M.D., et al.
Veröffentlicht: (2021)

Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
von: V. V. Pushkarov, et al.
Veröffentlicht: (2021)

Features of pleural cavity drainage in patients with acute nonspecific pleural empyema
von: D. V. Minukhin, et al.
Veröffentlicht: (2020)

Relationship between daily blood pressure profile and a marker of chronic systemic inflammation in patients with stage 2 essential hypertension with microalbuminuria
von: E. M. Vlasenko
Veröffentlicht: (2015)

Vitamin D in the complex treatment of diabetes type 2 patients
von: A. S. Yefimov, et al.
Veröffentlicht: (2014)

Іnfluence of excessive body mass on formation of systemic proinflammatory cytokine potential in patients with purulent-destructive forms of chronic nonspecific pulmonary diseases
von: Mindrul, M.A.
Veröffentlicht: (2013)

Specificity of perception and emotions in patients with schizophrenia with diabetes mellitus type 2
von: Ye. V. Opria
Veröffentlicht: (2018)

Insulin resistance indexes in patients with ischemic cardiac disease without diabetes mellitus during statine treatment
von: O. Bondarenko, et al.
Veröffentlicht: (2016)

The use of phosphodiesterase type 5 inhibitors in patients with type 2 diabetes mellitus and erectile dysfunction
von: Ye. Luchytskyi
Veröffentlicht: (2018)

Functional state of metabolic syndrome markers in traumatic disease in patients with increased body mass index
von: V. V. Kucheriavchenko, et al.
Veröffentlicht: (2019)

The effect of quercetin on oxidative stress markers and mitochondrial permeability transition in the heart of rats with type 2 diabetes
von: N. I. Gorbenko, et al.
Veröffentlicht: (2019)

Overall haemostasis potential of the blood plasma and its relation to some molecular markers of the hemostasis system in patients with chronic renal disease of stage VD
von: B. G. Storozhuk, et al.
Veröffentlicht: (2018)

Method of diagnosis nonalcoholic fatty liver in patients with type 2 diabetes mellitus
von: K. Kvit, et al.
Veröffentlicht: (2017)

The role of apoptosis in the combined course of chronic obstructive pulmonary disease and type 2 diabetes mellitus
von: N. K. Sukhonos
Veröffentlicht: (2017)

Comparative analysis of epigenetic markers in plasma and tissue of patients with colorectal cancer
von: A. G. Kondratov, et al.
Veröffentlicht: (2014)

Comparative analysis of epigenetic markers in plasma and tissue of patients with colorectal cancer
von: Kondratov, A.G., et al.
Veröffentlicht: (2014)

determination of the inflammation cellular mechanisms effect on the development of anemia in patients with pulmonary tuberculosis
von: O. O. Hovardovska
Veröffentlicht: (2019)

Sortylin influence on the indicators of carbohydrate metabolism at combination of coronary artery disease and type 2 diabetes mellitus
von: A. O. Sypalo
Veröffentlicht: (2017)

Glycemic control in prevention of cardiovascular diseases in diabetes mellitus
von: A. N. Korzh
Veröffentlicht: (2019)

Q192R polymorphism of PON-1 gene in type 2 diabetic patients
von: Ju. Gorshunskaja, et al.
Veröffentlicht: (2011)

Effect of cryopreserved fetal nerve cells on markers of immune inflammation of brain tissue under development of ischemic stroke
von: D. V. Lebedinets, et al.
Veröffentlicht: (2010)

Metabolism features of haptoglobin as inflammation acute phase protein in patients with chronic HCV infection
von: K. V. Yurko, et al.
Veröffentlicht: (2020)

Optimization of treatment of patients with acute cerebrovascular accident and type 2 diabetes mellitus in the stage of decompensation
von: Yu. I. Rzhevska, et al.
Veröffentlicht: (2020)

Effects of trimethylamine-n-oxide inhibitor in combination with anticholinesterase in patients with type 2 diabetes mellitus
von: O. Kikhtiak, et al.
Veröffentlicht: (2018)

Dynamics of IL-8 level and TGF-β1 of active form in blood serum under influence of excessive body mass in patients with purulent-destructive forms of chronic nonspecific pulmonary diseases
von: Mindrul, M.A.
Veröffentlicht: (2013)

Characteristics of Endothelial dysfunction in patients with Diabetes mellitus
von: A. S. Kuznetsova, et al.
Veröffentlicht: (2018)

Intra-abdominal hypertension in patients with diabetic ketoacidosis
von: V. Y. Lysenko, et al.
Veröffentlicht: (2014)

Levels of malondialdehyde and magnesium and the activity of catalase and glutathione reductase as markers of oxidative stress in the erythrocytes of patients with Ischemic Heart Disease
von: Chachoua, I., et al.
Veröffentlicht: (2010)